David Sidransky

发表

Comparative mutational landscape analysis of patient-derived tumour xenografts

Elana J Fertig, Luciane T Kagohara, Mariana Brait, 2017, British Journal of Cancer.

Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.

Qinghua Feng, David Sidransky, Amadou Dem, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis.

Paul Cairns, David Sidransky, M. Hoque, 2003, Cancer research.

Fine mapping of chromosome 3 in uveal melanoma: identification of a minimal region of deletion on chromosomal arm 3p25.1-p25.2.

David Sidransky, Vito M Fazio, D. Sidransky, 2003, Cancer research.

Gene expression alterations over large chromosomal regions in cancers include multiple genes unrelated to malignant progression.

Jonathan Pevsner, Nicole Benoit, David Sidransky, 2004, Proceedings of the National Academy of Sciences of the United States of America.

A Promoter Methylation Pattern in the N-Methyl-d-Aspartate Receptor 2B Gene Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma

Keishi Yamashita, David Sidransky, Joseph A Califano, 2007, Clinical Cancer Research.

Identification of AIM1 as a Hypermethylation-Inactivated Tumor Suppressor Gene in HNSCC

Rui Henrique, Carmen Jerónimo, David Sidransky, 2004 .

Identification of hypermethylated genes associated with cisplatin resistance in human cancers.

David Sidransky, Joseph A Califano, Steven S. Chang, 2010, Cancer research.

High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array.

Keishi Yamashita, David Sidransky, Juna Lee, 2003, Cancer research.

Activation of the NOTCH pathway in head and neck cancer.

Michael F. Ochs, Ashish Choudhary, Yan Liu, 2014, Cancer research.

Microsatellite alterations in serum DNA of head and neck cancer patients

David Sidransky, D. Sidransky, W. Koch, 1996, Nature Medicine.

Genetic and Epigenetic Analysis of erbB Signaling Pathway Genes in Lung Cancer

Mariana Brait, David Sidransky, M. Hoque, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer.

Rui Henrique, Carmen Jerónimo, David Sidransky, 2002, Urology.

Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival

David Sidransky, Kumari Wickramasinghe, D. Sidransky, 2001, Oncogene.

Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition

Meenakshi Malhotra, Alan Bilsland, Amr Amin, 2015, Seminars in cancer biology.

Fluorescence Visualization in Oral Neoplasia: Shedding Light on an Old Problem

David Sidransky, D. Sidransky, W. Westra, 2006, Clinical Cancer Research.

Efficacy of weekly docetaxel and bevacizumab in mesenchymal chondrosarcoma: a new theranostic method combining xenografted biopsies with a mathematical model.

Zvia Agur, David Sidransky, M. Wick, 2008, Cancer research.

Detection of bladder cancer recurrence by microsatellite analysis of urine

David Sidransky, D. Sidransky, L. Mao, 1997, Nature Medicine.

MicroRNA alterations in head and neck squamous cell carcinoma

David Sidransky, Steven S. Chang, J. Califano, 2008, International journal of cancer.

Early Occurrence of RASSF1A Hypermethylation and Its Mutual Exclusion with BRAF Mutation in Thyroid Tumorigenesis

Yoram Cohen, Giovanni Tallini, David Sidransky, 2004, Cancer Research.

p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study.

Nicole Benoit, David Sidransky, Michael P McDermott, 2003, Journal of the National Cancer Institute.

Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions

Paula Monteiro, Rui Henrique, David Sidransky, 2008, Breast Cancer Research and Treatment.

DNA methylation markers in colorectal cancer

David Sidransky, Juna Lee, D. Sidransky, 2010, Cancer and Metastasis Reviews.

Selective growth inhibition in BRAF mutant thyroid cancer by the mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244.

David Sidransky, Ning Jin, A. Dackiw, 2007, The Journal of clinical endocrinology and metabolism.

Overexpression of glycosylphosphatidylinositol (GPI) transamidase subunits phosphatidylinositol glycan class T and/or GPI anchor attachment 1 induces tumorigenesis and contributes to invasion in human breast cancer.

Xin Huang, Aditi Chatterjee, David Sidransky, 2006, Cancer research.

A p53-type response element in the GDF15 promoter confers high specificity for p53 activation.

David Sidransky, Guojun Wu, B. Trink, 2007, Biochemical and biophysical research communications.

Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment

Alfonso Valencia, Manuel Hidalgo, Samuel V. Angiuoli, 2014, Clinical Cancer Research.

Emerging molecular markers of cancer

David Sidransky, D. Sidransky, 2002, Nature Reviews Cancer.

Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites

Mei Zhao, David Sidransky, Gary L Clayman, 2011, Clinical Cancer Research.

Somatic mutation and gain of copy number of PIK3CA in human breast cancer

Xin Huang, David Goldenberg, Aditi Chatterjee, 2005, Breast Cancer Research.

Long-Term Cigarette Smoke Exposure and Changes in MiRNA Expression and Proteome in Non-Small-Cell Lung Cancer.

T S Keshava Prasad, Jayshree Advani, Yashwanth Subbannayya, 2017, Omics : a journal of integrative biology.

Genetic and Epigenetic screening for gene alterations of the chromatin‐remodeling factor, SMARCA4/BRG1, in lung tumors

David Sidransky, Manel Esteller, Julian Carretero, 2004, Genes, chromosomes & cancer.

Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study.

Yoram Cohen, David Sidransky, H. Boezen, 2004, Molecular cancer research : MCR.

Molecular staging of head and neck squamous carcinoma

Joseph A. Brennan, David Sidransky, D. Sidransky, 1996, Cancer and Metastasis Reviews.

The effect of aquaporin 5 overexpression on the Ras signaling pathway.

David Sidransky, Se Jin Jang, C. Moon, 2008, Biochemical and biophysical research communications.

Proteomic analysis of cancer-cell mitochondria

Mukesh Verma, Sudhir Srivastava, Jacob Kagan, 2003, Nature Reviews Cancer.

PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.

Yoichi Tanaka, Keishi Yamashita, David Sidransky, 2005, Cancer research.

PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.

Elisabeth Brambilla, David Sidransky, Julian Carretero, 2015, Cancer research.

ATM kinase is a master switch for the Delta Np63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage.

Yiping Huang, Jatin Nagpal, David Sidransky, 2008, Cell cycle.

Identification of mtDNA mutations in human cancer.

David Sidransky, S. Nomoto, D. Sidransky, 2002, Methods in molecular biology.

ATM kinase is a master switch for the ΔNp63α phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage

Yiping Huang, David Sidransky, B. Trink, 2008 .

Patient-derived xenografts for individualized care in advanced sarcoma

David Sidransky, Robert Maki, R. Maki, 2014, Cancer.

Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma.

Katsuya Yamashita, Akimasa Nakao, David Sidransky, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cancer epigenetics: above and beyond

Mariana Brait, David Sidransky, D. Sidransky, 2011, Toxicology mechanisms and methods.

Association between Lifestyle Factors and CpG Island Methylation in a Cancer-Free Population

Mariana Brait, David Sidransky, Jean G. Ford, 2009, Cancer Epidemiology, Biomarkers & Prevention.

p63 Transcriptional Regulation of Epithelial Integrity and Cancer

David Sidransky, B. Trink, D. Sidransky, 2007, Cell cycle.

Common pathway signature in lung and liver fibrosis

Anthony Atala, Alex Zhavoronkov, Anton Buzdin, 2016, Cell cycle.

The Oral Cavity as a Molecular Mirror of Lung Carcinogenesis

David Sidransky, D. Sidransky, 2008, Cancer Prevention Research.

Differential Recognition of Response Elements Determines Target Gene Specificity forp53 and p63

Keishi Yamashita, David Sidransky, S. Nomoto, 2005, Molecular and Cellular Biology.

Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients

Alexander M Aliper, Evgeny Izumchenko, David Sidransky, 2015, Human Genome Variation.

Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome.

Akhilesh Pandey, Aditi Chatterjee, Arivusudar Marimuthu, 2013, Biochimica et biophysica acta.

MT1G Hypermethylation Is Associated with Higher Tumor Stage in Prostate Cancer

Rui Henrique, Carmen Jerónimo, David Sidransky, 2005, Cancer Epidemiology Biomarkers & Prevention.

Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.

David Sidransky, Manel Esteller, S. Nomoto, 2002, Cancer research.